Natalizumab and Efalizumab Use

Project Title Natalizumab and Efalizumab Use
Date Posted
Thursday, December 13, 2012
Project ID
MSY2_STR89
Status
Complete
Deliverables
Description

Summary table assessment of the use of Natalizumab and Efalizumab. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in August 2011. This report includes data from 15 Data Partners.

This document is an Excel spreadsheet that includes multiple layers of data configured using pivot tables. If you do not have Excel, click here to obtain a free version of Microsoft’s Excel Viewer.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
efalizumab
natalizumab
Time Period
2004 - 2010
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER